ATX-MS-1467

BIOLOGICAL2 trials

Sponsors

Apitope Technology (Bristol) Ltd., Merck KGaA, Darmstadt, Germany

Conditions

Multiple SclerosisRelapsing Remitting Multiple Sclerosis

Phase 1

ATX-MS-1467 in Patients With Relapsing Forms of Multiple Sclerosis

CompletedNCT01097668

Apitope Technology (Bristol) Ltd.Relapsing Remitting Multiple Sclerosis

Start: 2010-03-31End: 2013-07-31Updated: 2015-02-16

Phase 2

ATX-MS-1467 in Multiple Sclerosis

CompletedNCT01973491

Merck KGaA, Darmstadt, GermanyMultiple Sclerosis

Start: 2014-02-28End: 2016-04-30Updated: 2017-07-02